ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $837,000 | -2.0% | 11,904 | -1.1% | 0.01% | 0.0% |
| Q3 2016 | $854,000 | +6.2% | 12,039 | -26.8% | 0.01% | 0.0% |
| Q2 2016 | $804,000 | +1.9% | 16,453 | +32.0% | 0.01% | 0.0% |
| Q1 2016 | $789,000 | -53.3% | 12,464 | -17.2% | 0.01% | -50.0% |
| Q4 2015 | $1,690,000 | +16.1% | 15,059 | -0.4% | 0.01% | +20.0% |
| Q3 2015 | $1,456,000 | -38.8% | 15,120 | -34.9% | 0.01% | -33.3% |
| Q2 2015 | $2,379,000 | +22.1% | 23,234 | -26.0% | 0.02% | +66.7% |
| Q1 2015 | $1,949,000 | +17.9% | 31,386 | -16.7% | 0.01% | +28.6% |
| Q4 2014 | $1,653,000 | -38.7% | 37,673 | -21.0% | 0.01% | -36.4% |
| Q3 2014 | $2,698,000 | +15.8% | 47,682 | -8.1% | 0.01% | +10.0% |
| Q2 2014 | $2,330,000 | +97.0% | 51,907 | +114.6% | 0.01% | +100.0% |
| Q1 2014 | $1,183,000 | – | 24,187 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |